You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
精華製藥(002349.SZ)子公司森萱醫藥擬在新三板公開發行股票並在精選層掛牌輔導備案
格隆匯 02-17 18:49

格隆匯2月17日丨精華製藥(002349.SZ)公佈,中國證券監督管理委員會於2019年12月20日發佈了《關於修改 <非上市公眾公司監督管理辦法> 的決定》、《非上市公眾公司信息披露管理辦法》;2019年12月27日,全國中小企業股份轉讓系統有限責任公司發佈了《全國中小企業股份轉讓系統分層管理辦法》、《全國中小企業股份轉讓系統股票交易規則》、《全國中小企業股份轉讓系統投資者適當性管理辦法》等制度。

公司控股子公司江蘇森萱醫藥股份有限公司(“森萱醫藥”)為全國中小企業股份轉讓系統(“新三板”)創新層掛牌企業,股票簡稱:森萱醫藥,股票代碼:830946,公司持有其84.14%股份。為進一步提升森萱醫藥在資本市場核心競爭力,充分迎接新三板改革發展成果,森萱醫藥將根據中國證券監督管理委員會、中國證券監督管理委員會江蘇監管局和全國中小企業股份轉讓系統有限責任公司的相關要求,與主辦券商開源證券股份有限公司簽署《輔導協議》,並擇機申報全國中小企業股份轉讓系統股票向不特定合格投資者公開發行並在精選層掛牌輔導備案。

森萱醫藥股票向不特定合格投資者公開發行並在股轉系統精選層掛牌具體方案公司將另行召開董事會予以審議,並報國資部門批覆,具體方案需經全國中小企業股份轉讓系統有限責任公司審批和中國證券監督管理委員會核准,是否通過審核尚存在不確定性。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account